1540O - Fosaprepitant reduces the impact of nausea on daily function during five weeks of chemo-radiotherapy: A sub-study of the GAND-emesis trial
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2017 28 Supplement 5:v543-v543 - Subject
- Language
- ISSN
- 0923-7534